New cancer drug shows promise in early trial for advanced tumors
Disease control
Recruiting now
This early-phase study tests a new drug called CCI-001 in people with advanced solid tumors that have come back or spread. The main goals are to check the drug's safety and find the best dose. About 70 participants will receive CCI-001 alone or with standard chemotherapy drugs li…
Phase: PHASE1 • Sponsor: PharmaMatrix Holdings Ltd • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC